Moderna has entered into a 15-year collaboration agreement with Thermo Fisher Scientific to enable dedicated large-scale US manufacturing of Spikevax, the former’s Covid-19 vaccine as well as other investigational messenger RNA (mRNA) medicines in its pipeline. The agreement is said to make use of exclusive commercial fill-finish manufacturing capacity in the US for mRNA vaccines […]
Moderna has signed a manufacturing services and supply agreement with Samsung Biologics under which the latter will undertake large scale, commercial fill-finish manufacturing for the mRNA-1273 COVID-19 vaccine. According to Samsung Biologics, technology transfer will begin immediately at the company’s facilities in Incheon, South Korea. The South Korean CDMO will use a production line equipped […]
Moderna and Laboratorios Farmacéuticos Rovi have entered into a collaboration for large-scale, commercial fill-finish manufacturing of mRNA-1273, the former’s mRNA vaccine candidate against COVID-19, at the latter’s facility in Madrid, Spain. Under the agreement terms, ROVI will offer vial filling and packaging capacity by procuring a new production line and equipment for compounding, filling, automatic […]